Profiles of drug substances, excipients, and related methodology. (notice n° 28727)
| 000 -LEADER | |
|---|---|
| fixed length control field | 04654cam a2200517Ki 4500 |
| 001 - CONTROL NUMBER | |
| control field | ocn785414367 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20211202100805.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cn||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120411s2011 caua ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | OPELS |
| Language of cataloging | eng |
| Transcribing agency | OPELS |
| Modifying agency | OCLCO |
| -- | OCLCQ |
| Description conventions | rda |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780123972200 (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0123972205 (electronic bk.) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)785414367 |
| 037 ## - SOURCE OF ACQUISITION | |
| Stock number | 1122311:11141961 |
| Source of stock number/acquisition | Elsevier Science & Technology |
| Note | http://www.sciencedirect.com |
| 050 14 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM300 |
| Item number | .P7636 2011eb |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.1901 |
| Edition number | 23 |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | TEFA |
| 245 00 - TITLE STATEMENT | |
| Title | Profiles of drug substances, excipients, and related methodology. |
| Number of part/section of a work | Volume 36 / |
| Statement of responsibility, etc | edited by Harry G. Brittain. |
| 264 #1 - | |
| -- | San Diego ; |
| -- | Waltham, Mass. : |
| -- | Elsevier Academic Press, |
| -- | 2011. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | ix, 388 pages : |
| Other physical details | illustrations ; |
| Dimensions | 23 cm. |
| 336 ## - CONTENT TYPE | |
| Content Type Term | text |
| Content Type Code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media Type Term | computer |
| Media Type Code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier Type Term | online resource |
| Carrier Type Code | cr |
| Source | rdacarrier |
| 347 ## - | |
| -- | data file |
| -- | rda |
| 380 ## - | |
| -- | Bibliography |
| 490 1# - SERIES STATEMENT | |
| Series statement | Profiles of drug substances, excipients, and related methodology ; |
| Volume number/sequential designation | 36 |
| 533 ## - REPRODUCTION NOTE | |
| Type of reproduction | Electronic reproduction. |
| Place of reproduction | Amsterdam : |
| Agency responsible for reproduction | Elsevier Science and Technology, |
| Date of reproduction | 2012. |
| Note about reproduction | Mode of access: World Wide Web. |
| -- | System requirements: Web browser. |
| -- | Title from title screen (viewed on Apr. 4, 2012). |
| -- | Access may be restricted to users at subscribing institutions. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Volumes in this widely revered series present comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. This organizational structure meets the needs of the pharmaceutical community and allows for the development of a timely vehicle for publishing review materials on this topic. The scope of the Profiles series encompasses review articles and database compilations that fall within one of the following six broad categories: Physical profiles of drug substances and excipients; Analytical profiles of drug substances and excipients; Drug metabolism and pharmacokinetic profiles of drug substances and excipients; Methodology related to the characterization of drug substances and excipients; Methods of chemical synthesis; and Reviews of the uses and applications for individual drug substances, classes of drug substances, or excipients. * Presents comprehensive reviews covering all aspects of drug development and formulation of drugs * Profiles creatine monohydrate and fexofenadine hydrochloride, as well as five others * Meets the information needs of the drug development community. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Aripiprazole: Polymorphs and Solvatomorphs Harry G. Brittain Amlodipine Besylate Gennady Ananchenko, Jasmina Novakovic and Johnathan Lewis Candesartan cilexetil Febry Ardiana, Maria L. A. D. Lestari and Gunawan Indrayanto Flurbiprofen Alaa A.-M. Abdel-Aziz, Abdullah A. Al-Badr and Gamal Abdel Hafez Gatifloxacin Ebtehal S. Al-Abdullah Lamotrigine Kevin Beattie, Geeta Phadke and Jasmina Novakovic Pimozide Robert Smyj, Xiao-Ping Wang and Feixue Han Risperidone David Germann, Natalie Kurylo and Feixue Han Sunitinib Malate Mohammed Gabr Kassem, A.F.M. Motiur Rahman , Hesham M. Korashy Varenicline Mohammed Gabr Kassem, Abdullah M. Al Hossaini Zolpidem Tartrate Nagwa H. Foda, Shaimaa M. Badr-Eldin Validation of Analytical Methods - Update 2011 Gunawan Indrayanto. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter 1: Buclizine -- Chapter 2: Chitin -- Chapter 3: Ezetimibe -- Chapter 4: Gemifloxacin -- Chapter 5: Glimepiride -- Chapter 6: Lornoxicam -- Chapter 7: Magnesium Silicate -- Chapter 8: Tadalafil -- Chapter 9: Direct Crystallization of Enantiomers and Dissociable Diastereomers -- Chapter 10: Cocrystal Systems of Pharmaceutical Interest: 2009. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drugs |
| General subdivision | Analysis. |
| 9 (RLIN) | 40560 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Excipients |
| General subdivision | Analysis. |
| 9 (RLIN) | 40561 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pharmaceutical chemistry. |
| 9 (RLIN) | 40562 |
| 655 #7 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| Source of term | local |
| 9 (RLIN) | 20 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brittain, H. G. |
| 9 (RLIN) | 40563 |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | ScienceDirect (Online service) |
| 9 (RLIN) | 24918 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Print version: |
| Title | Profiles of drug substances, excipients, and related methodology. Volume 36. |
| Place, publisher, and date of publication | San Diego ; Waltham, Mass. : Elsevier Academic Press, 2011 |
| International Standard Book Number | 9780123876676 |
| Record control number | (OCoLC)759477955 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Profiles of drug substances, excipients, and related methodology ; |
| Volume number/sequential designation | 36. |
| 9 (RLIN) | 40564 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://www.sciencedirect.com/science/book/9780123972200">http://www.sciencedirect.com/science/book/9780123972200</a> |
| Public note | An electronic book accessible through the World Wide Web; click for information |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Ebook |
| 956 ## - LOCAL ELECTRONIC LOCATION AND ACCESS (OCLC) | |
| Electronic name | Consortium |
| 994 ## - | |
| -- | C0 |
| -- | TEF |
Pas d'exemplaire disponible.
